SYNERON MEDICAL LTD's ticker is ELOS and the CUSIP is M87245102. A total of 4 filers reported holding SYNERON MEDICAL LTD in Q3 2017. The put-call ratio across all filers is - and the average weighting 23.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $5,600,000 | – | 511,420 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 706,107 | $5,931,000 | 5.46% |
| NORTH TIDE CAPITAL, LLC | 3,500,000 | $29,400,000 | 5.03% |
| Senvest Management, LLC | 3,777,775 | $31,733,000 | 2.26% |
| Kenmare Capital Partners, L.L.C. | 269,839 | $2,267,000 | 1.72% |
| Camber Capital Management LP | 2,347,593 | $19,720,000 | 1.03% |
| DALTON GREINER HARTMAN MAHER & CO | 1,785,826 | $15,001,000 | 0.88% |
| PERRITT CAPITAL MANAGEMENT INC | 425,170 | $3,571,000 | 0.87% |
| Profit Investment Management, LLC | 88,777 | $746,000 | 0.70% |
| DAFNA Capital Management LLC | 85,947 | $722,000 | 0.63% |
| Lapides Asset Management, LLC | 396,800 | $3,333,000 | 0.60% |